# Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel

> **NCT06043921** · — · RECRUITING · sponsor: **Invitae Corporation** · enrollment: 150 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06043921
- **Lead sponsor:** Invitae Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043921, "Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06043921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
